The HCPLive rheumatoid arthritis page is a comprehensive resource for clinical news and insights on arthritis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for RA, and more.
May 16th 2024
A real-world study from Spain suggests baricitinib demonstrated favorable effectiveness, adherence, and safety in rheumatoid arthritis, but investigators caution more research is needed.
More Studies Validate HA Shots for Knee OA
May 5th 2015(OARSI2015) A new systematic review found intra-articular hyaluronic acid mildly effective for knee osteoarthritis pain, despite significant weaknesses and risks of bias in the trials. Another study using a large database found that the injections delay knee replacement.
Rheumatoid Arthritis Patients at Increased Risk for Cardiovascular Death
May 4th 2015In addition to recent research that used genetic factors to predict the severity of rheumatoid arthritis (RA), another development suggests that patients have an increased risk of a surprise heart attack even without showing symptoms.
Rheumatoid Arthritis May Be Triggered by Mouth Bacteria
Inflammation in the gums and mouth bacteria may be a trigger behind the onset of rheumatoid arthritis, according to findings presented at the 93rd General Session and Exhibition of the International Association for Dental Research.
Evaluating a Young Patient with Joint Pain and Stiffness Part 2
You see a 29-year-old female insurance saleswoman with a 6-week history of joint pains and swelling affecting both hands and wrists, both feet and her left knee. Her symptoms are worse when she first gets up in the morning and it takes a few hours before her joints seem to loosen up.
Insulin Resistance Higher in Rheumatoid Arthritis Patients
The increased insulin resistance seen in rheumatoid arthritis (RA) patients compared to non-RA controls did not contribute to additional atherosclerosis risk, according to research published in Arthritis & Rheumatology.
Safely Discontinuing DMARD Treatment in Patients with Rheumatoid Arthritis
Discontinuing disease-modifying anti-rheumatic drug (DMARD) therapy in patients with rheumatoid arthritis who have achieved remission is safe, according to research published in the Annals of Rheumatic Diseases.
Scientists Identify Mechanism of Action of Potential Psoriasis Therapy
March 12th 2015Researchers in Germany have figured out the process by which interleukin 4 (IL-4) inhibits inflammation, pointing the way toward a possible treatment for psoriasis, psoriatic arthritis, and other autoimmune diseases.
New Rheumatoid Arthritis Patient Care Model Leads to Significant Cost Reductions
Rheumatoid arthritis patient care costs can be reduced using the Attribution, Integration, Measurement, Finances and Reporting of Therapies (AIM FARTHER) model developed by researchers at Geisinger Health System in Central Pennsylvania.